Notch信号分子在血热型银屑病患者单个核细胞中的表达
|
摘要
银屑病俗称“牛皮癣”,中医称之为“白疙”,目前被认为是一种以红斑鳞屑为主要临床表现的慢性、炎症性皮肤病,通常侵犯皮肤和关节,且易复发。近年来发病率有逐渐增高的趋势,银屑病的确切病因仍有待研究,多数专家认为银屑病是由遗传因素和环境因素等多种因素相互交织作用所导致。其整个发病过程受到细胞因子网络与多种信号通路的调控。
Notch信号通路由Notch受体、Notch配体和CSL DNA结合蛋白三部分组成。广泛分布于造血干细胞,胚胎干细胞,淋巴细胞,血管内皮细胞等多种细胞表面。研究结果表明,Notch信号在银屑病的真皮处于活化状态,可通过影响T细胞的发育、活化及调节细胞因子的分泌参与银屑病的发生。有研究显示在包括角质形成细胞等多种表皮细胞的表面,Notch及其配体均有大量表达,且特异性的Notch信号活化在维持皮肤细胞自身更新及分化过程中起重要作用。异常的Notch信号可能有助于揭示银屑病等皮肤疾病的发病机制。
目前国内外药物干预Notch信号通路治疗银屑病的研究仍处于空白阶段,作用机理研究更为匮乏。因此,从免疫调节角度进行调控Notch信号通路治疗银屑病的药物研究十分必要,且具备广泛的探索空间。血热型银屑病相当于银屑病的初期(急性期)是临床表现最典型且多见的类型,祛银颗粒是导师白彦萍教授的自拟方药,以清热凉血解毒中药为主要成分,其良好的临床疗效已通过前期的临床及动物模型研究得到证实。但其具体作用机制和作用靶点尚不清楚。本研究旨在从分子生物学角度探讨Notch信号传导分子是否在血热型银屑病患者中发挥一定的作用。了解各传导分子的活跃情况将有助于支持后续清热凉血方药对Notch信号通路调控的相关研究。
目的：揭示血热型银屑病患者单个核细胞中Notch信号分子(Notch1-4、Delta1、 Delta3-4、Jaggedl-2)的表达情况,并对银屑病患者的病情严重程度与Notch信号分子的表达关系做出客观评价。
方法：收集纳入血热型银屑病患者,进行PAS I评分并采集患者外周血,提取出单个核细胞。以健康人为参照,分别采用实时荧光定量PCR法检测27例血热型患者和27例健康人的Notch信号分子mRNA表达水平；运用流式细胞术对6例血热型银屑病患者和5例健康人的Notch信号分子平均荧光强度的表达进行检测；采用蛋白免疫印记法(Western Blot)检测血热型银屑病30例和健康人30例的Notch信号通路的相关蛋白表达。
结果：(1)血热型银屑病患者单个核细胞中Notch2的mRNA水平较健康人显著升高,两者间差异有统计学意义,P=0.036(P<0.05),其表达与PASI评分呈正相关趋势。
(2)血热型银屑病患者单个核细胞中Notch3的mRNA水平较健康人显著降低,两者间有显著性差异,P=0.008(P<0.01),未发现其表达与PASI评分呈正相关趋势。
(3) Notch1、Notch4、Jagged1-2、Delta1、Delta3-4,在血热型银屑病患者单个核细胞中的mRNA水平较健康人无明显差异,两者间无统计学意义(P>0.05)。
(4)血热型银屑病患者组的Notch2平均荧光强度(MFI)低于健康人对照组的Notch2MFI表达水平,两者比较有显著差异(P<0.01),其与PASI评分无明显相关性。
(5)血热型银屑病患者组的Notch1、Noth3平均荧光强度(MFI)与健康人对照组的Notch1、Noth3MFI两者比较无统计学意义(P>0.05)。
(6) Western Blot显示健康人组与血热型患者组比较,血热型患者组Delta4蛋白表达明显上调,有显著统计学差异(P<0.01)。其与PASI评分无明显相关性。
(7) Western Blot显示健康人组与血热型患者组比较,Notch1、Deltal蛋白表达无明显差异,两者间无统计学意义(P>0.05)。
结论：Notch2在mRNA和蛋白表达方面较健康人均有所升高,Delta4的蛋白表达较健康人升高。其中Notch2mRNA与表达与银屑病的严重程度呈正相关；Notch3mRNA表达较健康人有所下降,但其与银屑病的严重程度无明显相关性。Notch信号通路参与了血热型银屑病的发生、发展等调节过程。
Background:Psoriasis, also known as "Niu Pi Xuan", or called "Bai Bi" in Traditional Chinese Medicine (TCM), currently has been regarded as a kind of chronic skin disease of inflammation, relatively appeared in clinic with erythema scale as its main clinic symptom. It often occurs on skin and joints and easily relapses. The incidence of psoriasis is gradually increasing in recent years; however, the specific causes of psoriasis are still unclear. Most experts believe psoriasis is a genetic disease related to multiple genes, which is caused and affected by the interaction of multiple factors, such as genetic and environmental factors. During the whole progress of disease, it is influenced and regulated by multiple complex cytokine networks and signaling pathways.
Notch signaling pathway consists of Notch acceptors, Notch ligands and CSL DNA-binding protein. It is widely distributed in the surface of multiple cells, such as hematopoietic stem cells, embryonic stem cells, lymphocytes, and vascular endothelial cells. Some studies show that Notch signal is activated in the dermis, and it can promote the onset of psoriasis by influencing the development and activation of T cells and regulating the secretion of cytokine. Some studies indicate that there is high expression of Notch and its ligand in the surface of keratinocyte and other epidermal cells and the specific activation of Notch signaling plays an important role for maintaining the skin cells' renewal and differentiation. Therefore, abnormal Notch signals possibly help to reveal the pathogenesis of psoriasis and other skin diseases.
To date, there is no domestic or overseas research exploring certain medications for the treatment of psoriasis by regulating the Notch signaling pathway, and research on the mechanism of the treatment is even rarer. Therefore, it is extremely necessary to conduct an intervention study from immune regulation perspective to treat psoriasis by regulating Notch signaling pathway. Blood-heat psoriasis, equivalent to the initial stage or acute stage of psoriasis, is the most typical and common type of psoriasis in clinical practice. Qu Yin Granules is a self-prescribed prescription by Doctoral Supervisor and Professor Bai Yanping. Its essential components consist of Chinese herbal medicines with functions of clearing heat, cooling blood and resolving toxins. We has confirmed its beneficial effects on psoriasis by previous clinical studies and animal experiments. However, the specific mechanism and the action target are still unclear. This study aims at probing whether the Notch signal transduction molecules play a role or not in blood-heat psoriasis from the perspective of molecular biology. Understanding of the active situation of the transduction molecules will support future research on the regulation of Notch signaling pathway by clearing-heat and cooling-blood medications, which will lay a foundation for revealing the whole mechanism of the treatment.
Purposes:The purposes of this research are to reveal the expression of Notch signaling molecules (Notch1-4, Deltl, Delt3-4and Jagged1-2) in mononuclear cells of blood-heat psoriasis patients, and to objectively evaluate the relationship between the psoriasis severity and the expression of Notch signaling molecules, and to explore target protein molecules for the regulation of Notch signaling pathway.
Methods:27blood-heat psoriasis patients confirmed under the guidance of TCM theory were allocated in the experimental group and graded with PASI scores, with27health participants as control. We collected the peripheral blood samples of all participants to extract their mononuclear cells. Real-time fluorescent quantitation PCR method was used to detect the expression levels of mRNA of Notch signaling molecules of all participants. Flow cytometry was used to record expressions of the mean fluorescence intensity (MFI) of Notch signaling molecules in6blood-heat psoriasis patients and5healthy participants. Western Blotting was used to detect the expression of proteins related to Notch signaling molecules of30participants in experimental group and30healthy participants in control group.
Results:(1)Compared with healthy participants, blood-heat psoriasis patients had a marked increase of mRNA level of Notch2in mononuclear cells. There was a significant difference between groups, P=0.036(P＜0.05). The expression was positively correlated with PASI scores.
(2)Compared with healthy participants, blood-heat psoriasis patients had an obvious decrease of mRNA level of Notch3in mononuclear cells. There was a significant difference between groups, P=0.008(P＜0.01). The positive correlation between the expression and PASI scores was not detected.
(3)Compared with healthy participants, there were no specific changes of Notchl, Notch4, Jaggedl-2, Deltal and Delta3-4in blood-heat psoriasis patients. There was no significant difference between them.(P＞0.05)
(4)There was significant statistical difference (P＜0.01) for Notch2MFI between experimental group and healthy group. The PASI correlation analysis showed that the Notch2's flow MFI expression was independent of the psoriasis severity.
(5) There was no statistical significance between the MFI of Notchl and Notch3of experimental group and Notchl MFI of healthy group.
(6) Western Blotting showed that there was an obvious increase of Delta4protein expression, with significant statistical difference (P＜0.01). The PASI correlation analysis showed that Delta4protein was independent of the psoriasis severity.
(7)Western Blotting showed that there was no difference (P＞0.05) for Notchl or Delta4protein expression between experimental group and healthy group.
Conclusions:The mRNA and protein expressions of Notch2of blood-heat psoriasis patients were higher than healthy participants, and the higher of mRNA level of Notch2, the severer of psoriasis, which indicates the direct relation between psoriasis severity and the activity level of Notch2. As Notch signaling molecule ligand, Delta4has directly participated in the course of blood-heat psoriasis. Though psoriasis participants had a decrease of Notch3mRNA expression, compared to healthy people, it cannot be used as diagnostic standards for psoriasis. Notch signaling pathway directly has participated in the onset and development of blood-heat psoriasis.
Notch信号通路由Notch受体、Notch配体和CSL DNA结合蛋白三部分组成。广泛分布于造血干细胞,胚胎干细胞,淋巴细胞,血管内皮细胞等多种细胞表面。研究结果表明,Notch信号在银屑病的真皮处于活化状态,可通过影响T细胞的发育、活化及调节细胞因子的分泌参与银屑病的发生。有研究显示在包括角质形成细胞等多种表皮细胞的表面,Notch及其配体均有大量表达,且特异性的Notch信号活化在维持皮肤细胞自身更新及分化过程中起重要作用。异常的Notch信号可能有助于揭示银屑病等皮肤疾病的发病机制。
目前国内外药物干预Notch信号通路治疗银屑病的研究仍处于空白阶段,作用机理研究更为匮乏。因此,从免疫调节角度进行调控Notch信号通路治疗银屑病的药物研究十分必要,且具备广泛的探索空间。血热型银屑病相当于银屑病的初期(急性期)是临床表现最典型且多见的类型,祛银颗粒是导师白彦萍教授的自拟方药,以清热凉血解毒中药为主要成分,其良好的临床疗效已通过前期的临床及动物模型研究得到证实。但其具体作用机制和作用靶点尚不清楚。本研究旨在从分子生物学角度探讨Notch信号传导分子是否在血热型银屑病患者中发挥一定的作用。了解各传导分子的活跃情况将有助于支持后续清热凉血方药对Notch信号通路调控的相关研究。
目的：揭示血热型银屑病患者单个核细胞中Notch信号分子(Notch1-4、Delta1、 Delta3-4、Jaggedl-2)的表达情况,并对银屑病患者的病情严重程度与Notch信号分子的表达关系做出客观评价。
方法：收集纳入血热型银屑病患者,进行PAS I评分并采集患者外周血,提取出单个核细胞。以健康人为参照,分别采用实时荧光定量PCR法检测27例血热型患者和27例健康人的Notch信号分子mRNA表达水平；运用流式细胞术对6例血热型银屑病患者和5例健康人的Notch信号分子平均荧光强度的表达进行检测；采用蛋白免疫印记法(Western Blot)检测血热型银屑病30例和健康人30例的Notch信号通路的相关蛋白表达。
结果：(1)血热型银屑病患者单个核细胞中Notch2的mRNA水平较健康人显著升高,两者间差异有统计学意义,P=0.036(P<0.05),其表达与PASI评分呈正相关趋势。
(2)血热型银屑病患者单个核细胞中Notch3的mRNA水平较健康人显著降低,两者间有显著性差异,P=0.008(P<0.01),未发现其表达与PASI评分呈正相关趋势。
(3) Notch1、Notch4、Jagged1-2、Delta1、Delta3-4,在血热型银屑病患者单个核细胞中的mRNA水平较健康人无明显差异,两者间无统计学意义(P>0.05)。
(4)血热型银屑病患者组的Notch2平均荧光强度(MFI)低于健康人对照组的Notch2MFI表达水平,两者比较有显著差异(P<0.01),其与PASI评分无明显相关性。
(5)血热型银屑病患者组的Notch1、Noth3平均荧光强度(MFI)与健康人对照组的Notch1、Noth3MFI两者比较无统计学意义(P>0.05)。
(6) Western Blot显示健康人组与血热型患者组比较,血热型患者组Delta4蛋白表达明显上调,有显著统计学差异(P<0.01)。其与PASI评分无明显相关性。
(7) Western Blot显示健康人组与血热型患者组比较,Notch1、Deltal蛋白表达无明显差异,两者间无统计学意义(P>0.05)。
结论：Notch2在mRNA和蛋白表达方面较健康人均有所升高,Delta4的蛋白表达较健康人升高。其中Notch2mRNA与表达与银屑病的严重程度呈正相关；Notch3mRNA表达较健康人有所下降,但其与银屑病的严重程度无明显相关性。Notch信号通路参与了血热型银屑病的发生、发展等调节过程。
Background:Psoriasis, also known as "Niu Pi Xuan", or called "Bai Bi" in Traditional Chinese Medicine (TCM), currently has been regarded as a kind of chronic skin disease of inflammation, relatively appeared in clinic with erythema scale as its main clinic symptom. It often occurs on skin and joints and easily relapses. The incidence of psoriasis is gradually increasing in recent years; however, the specific causes of psoriasis are still unclear. Most experts believe psoriasis is a genetic disease related to multiple genes, which is caused and affected by the interaction of multiple factors, such as genetic and environmental factors. During the whole progress of disease, it is influenced and regulated by multiple complex cytokine networks and signaling pathways.
Notch signaling pathway consists of Notch acceptors, Notch ligands and CSL DNA-binding protein. It is widely distributed in the surface of multiple cells, such as hematopoietic stem cells, embryonic stem cells, lymphocytes, and vascular endothelial cells. Some studies show that Notch signal is activated in the dermis, and it can promote the onset of psoriasis by influencing the development and activation of T cells and regulating the secretion of cytokine. Some studies indicate that there is high expression of Notch and its ligand in the surface of keratinocyte and other epidermal cells and the specific activation of Notch signaling plays an important role for maintaining the skin cells' renewal and differentiation. Therefore, abnormal Notch signals possibly help to reveal the pathogenesis of psoriasis and other skin diseases.
To date, there is no domestic or overseas research exploring certain medications for the treatment of psoriasis by regulating the Notch signaling pathway, and research on the mechanism of the treatment is even rarer. Therefore, it is extremely necessary to conduct an intervention study from immune regulation perspective to treat psoriasis by regulating Notch signaling pathway. Blood-heat psoriasis, equivalent to the initial stage or acute stage of psoriasis, is the most typical and common type of psoriasis in clinical practice. Qu Yin Granules is a self-prescribed prescription by Doctoral Supervisor and Professor Bai Yanping. Its essential components consist of Chinese herbal medicines with functions of clearing heat, cooling blood and resolving toxins. We has confirmed its beneficial effects on psoriasis by previous clinical studies and animal experiments. However, the specific mechanism and the action target are still unclear. This study aims at probing whether the Notch signal transduction molecules play a role or not in blood-heat psoriasis from the perspective of molecular biology. Understanding of the active situation of the transduction molecules will support future research on the regulation of Notch signaling pathway by clearing-heat and cooling-blood medications, which will lay a foundation for revealing the whole mechanism of the treatment.
Purposes:The purposes of this research are to reveal the expression of Notch signaling molecules (Notch1-4, Deltl, Delt3-4and Jagged1-2) in mononuclear cells of blood-heat psoriasis patients, and to objectively evaluate the relationship between the psoriasis severity and the expression of Notch signaling molecules, and to explore target protein molecules for the regulation of Notch signaling pathway.
Methods:27blood-heat psoriasis patients confirmed under the guidance of TCM theory were allocated in the experimental group and graded with PASI scores, with27health participants as control. We collected the peripheral blood samples of all participants to extract their mononuclear cells. Real-time fluorescent quantitation PCR method was used to detect the expression levels of mRNA of Notch signaling molecules of all participants. Flow cytometry was used to record expressions of the mean fluorescence intensity (MFI) of Notch signaling molecules in6blood-heat psoriasis patients and5healthy participants. Western Blotting was used to detect the expression of proteins related to Notch signaling molecules of30participants in experimental group and30healthy participants in control group.
Results:(1)Compared with healthy participants, blood-heat psoriasis patients had a marked increase of mRNA level of Notch2in mononuclear cells. There was a significant difference between groups, P=0.036(P＜0.05). The expression was positively correlated with PASI scores.
(2)Compared with healthy participants, blood-heat psoriasis patients had an obvious decrease of mRNA level of Notch3in mononuclear cells. There was a significant difference between groups, P=0.008(P＜0.01). The positive correlation between the expression and PASI scores was not detected.
(3)Compared with healthy participants, there were no specific changes of Notchl, Notch4, Jaggedl-2, Deltal and Delta3-4in blood-heat psoriasis patients. There was no significant difference between them.(P＞0.05)
(4)There was significant statistical difference (P＜0.01) for Notch2MFI between experimental group and healthy group. The PASI correlation analysis showed that the Notch2's flow MFI expression was independent of the psoriasis severity.
(5) There was no statistical significance between the MFI of Notchl and Notch3of experimental group and Notchl MFI of healthy group.
(6) Western Blotting showed that there was an obvious increase of Delta4protein expression, with significant statistical difference (P＜0.01). The PASI correlation analysis showed that Delta4protein was independent of the psoriasis severity.
(7)Western Blotting showed that there was no difference (P＞0.05) for Notchl or Delta4protein expression between experimental group and healthy group.
Conclusions:The mRNA and protein expressions of Notch2of blood-heat psoriasis patients were higher than healthy participants, and the higher of mRNA level of Notch2, the severer of psoriasis, which indicates the direct relation between psoriasis severity and the activity level of Notch2. As Notch signaling molecule ligand, Delta4has directly participated in the course of blood-heat psoriasis. Though psoriasis participants had a decrease of Notch3mRNA expression, compared to healthy people, it cannot be used as diagnostic standards for psoriasis. Notch signaling pathway directly has participated in the onset and development of blood-heat psoriasis.
引文
[1]国家中医药管理局,《中医临床诊断术语·疾病部分》[M].北京,1997.
[2]中医研究院广安门医院,朱仁康临床经验集[J].人民卫生出版社,1979,153-158.
[3]北京中医医院,赵炳南临床经验集[J].人民卫生出版社,1975,211-229.
[4]顾伯华外科经验集[J].上海人民出版社,1977,252.
[5]周鸣岐.辨证分型治疗银屑病302例[J].中医杂志,1989,30(5)：42-43.
[6]金起风.中华皮肤病学[J].中国医药科技出版社,2001,228-233.
[7]王萍,邓丙戌,孙丽蕴,张芃.张志礼中医辨证治疗银屑病方法及临床研究[J].中国中西医结合皮肤性病学杂志,2004,3(4)：19-193.
[8]于晓飞,吴秀艳,徐雯洁等.不同年代寻常型银屑病证候分布规律特点的现代文献研究[M].全国第十三届中医诊断学术年会论文汇编,2012：215-219.
[9]卢传坚,曾召,谢秀丽等.1979-2010年寻常型银屑病文献证候分布情况分析[J].中医杂志,2012,53(11)：959-961.
[10]谢知音,白彦萍,杨顶权.银屑病中医体质与辨证分型的相关性研究[J].中华中医药杂志.2009,(6)：823-825.
[11]皮巨川.犀角地黄汤加味治疗寻常型银屑病26例疗效观察[J],贵阳中医学院学报,1995,17(1)：57.
[12]张志礼,200例银屑病中医辨证论治的体会[J].中华医学杂志,1974,(4)：205-207.
[13]白英华,田静,凉血四根汤治疗血热型银屑病疗效观察[J].辽宁中医杂志,2006,11(33)：1433-1434.
[14]瞿幸,牛福玲,赵丽平.消银解毒饮治疗银屑病血热证85例临床研究[J].中医杂志,2001,42(2)：103-104.
[15]郝平生.加味凉血消风散治疗寻常型进行期血热证银屑病30例疗效观察[J].中药与临床,2011,2(3)：50-58.
[16]王素梅.皮炎汤治疗寻常型银屑病血热证的临床疗效[J].求医问药,2012,10(8)：160.
[17]徐明.清热凉血汤治疗寻常型银屑病血热证临床疗效观察[J].辽宁中医药大学学报,2013,15(1)：177-178.
[18]吕世超,赵梓刚,郭雁冰等.蛇花颗粒治疗寻常型银屑病(血热型)临床研究[J].中国中医药信息杂志,2008,7,15(7)：78-79.
[19]李娟,藏亮,黄婷等.生元饮治疗血热型银屑病的临床观察[J].黑龙江中医药,2010,3：16-17.
[20]刘志勇,王莒生,王萍等.凉血解毒汤治疗白疙(寻常型银屑病)血热证的临床观察[J].世界中西医结合杂志,2010,5(40)：317-320.
[21]李福伦,李斌,徐蓉等.芩珠凉血合剂治疗血热证银屑病的随机对照临床研究[J].中西医结合学 报,2008,6(6)：586-590.
[22]马丽俐,骆丰,余土根等.清热凉血方对血热型寻常型银屑病患者血清VEGF水平和PASI指数的影响[J].中国中医药科技,2008,15(3)：168-169.
[23]张春红,杜锡贤,张春敏.祛银汤治疗血热证银屑病临床观察及其对外周血OPN和VEGF表达的影响[J].中国皮肤性病学杂志,2011,25(3)：228-230.
[24]张红,徐晓光,顾军等.消银方治疗血热证型银屑病患者的疗效及对外周血Thl/Th2平衡的影响[J].中国中西医结合杂志,2008,28(8)：683-685.
[25]刘和平,孟凡颖.自拟养血润肤汤治疗血燥型银屑病40例疗效分析[J],中国医药导报,2011,08(5)：66.
[26]李忠信.养血祛风汤治疗寻常型银屑病40例疗效观察[J].山东中医杂志,2004,23(3)：149-150.
[27]周德瑛,张丰川,李元文等.养血消银解毒饮治疗寻常型银屑病血燥证52例[J].中国中医急症,2010,19(8)：1430-1431.
[28]陆茂,叶俊儒,张云光等.窄谱中波紫外线联合中药治疗血燥型银屑病的疗效观察[J].四川中医,2009,27(12)：102-103.
[29]张永.桃红四物汤治疗银屑病的方药研究探析[J],光明中医,2008,23(10)：1471-1472.
[30]王秀敏,于小玲,张其红.银屑病患者活血化瘀治疗前后血液流变学和甲襞微循环的变化[J].滨州医学院学报,1999,22(6)535-536.
[31]郭建辉,郭雯,付红娟等.从络病论治寻常型银屑病60例临床观察[J].中医药导报,2012,18(5)：32-33.
[32]邱实,谭升顺,孙治平等.活血散疲消银汤治疗寻常型银屑病血疲证的临床研究[J].中药材杂志,2005：25(5)：442-444.
[33]崔秀梅,柏燕军,卢淑梅等.养血消银颗粒剂治疗银屑病血虚证39例临床研究[A].2003中国中西医结合皮肤性病学术会议论文汇编[C],2003：503-504.
[34]范延华,孔连委,张文宪等.中药联合紫外光治疗银屑病血虚证60例[J].现代中西医结合杂志,2010,19(24)：3075.
[35]吴燕军,刘红霞,姚岚等.中医治疗银屑病的用药规律研究[J],北京中医药,2009,28(9)：701-702.
[36]张小蒙,雷公藤的药理作用和临床应用研究进展,临床合理用药杂志[J],2012,05(20)：180.
[37]周萌.银屑病血瘀证的思考[J],中国医学文摘(皮肤科学,2006,23(5)：337-338.
[38]梁莹,周萌.活血化瘀中药复方对小鼠银屑病模型的影响[J],中国医药导报2009,6(26)：9-11.
[39]高依卿,陈玉春.气血阴阳补益方剂影响免疫和造血功能的研究现状[J],中药材,2001,24(5)：383-385.
[40]邢捷.益气健脾、补益气血中药促进难愈性创面愈合的机制研究[D],上海中医药大学,硕士论 文,2007.
[41]李斌,王婕,范斌等.中医“血分论治”对寻常型银屑病患者外周血单个核细胞IFN-γ/IL-4表达影响的实验研究[J].上海中医药杂志,2007,41(11)：5-6.
[42]范斌,李斌,沈健雄等.凉血和活血中药对银屑病患者不同时期细胞因子的影响[J].中国中西医结合皮肤性病学杂志,2006,5(2)：70-71.
[43]夏梦,段行武,高永红等.消银解毒饮调控银屑病血热证肿瘤坏死因子-α的相关研究[J].中国中西医结合皮肤性病学杂志,2011,10(2)：79-82.
[44]刘志勇,王莒生,王萍等.凉血解毒汤治疗白疙(寻常型银屑病)血热证的临床观察[J].世界中西医结合杂志,2010,5(40)：317-320.
[45]王丽华,张蕾,刘欣等.养血解毒汤对血燥型银屑病患者血清免疫细胞因子的调节[J],辽宁中医药大学学报,2010,11(11)：69-71.
[46]林熙然.抑制血管生成与银屑病的中西医结合治疗研究[J],中国中西医结合皮肤性病学杂志,2006,5：187-191.
[47]刘国海,张晓云,刘俊敏等.活血化瘀法治疗银屑病疗效与血液流变学变化的关系[J],临床皮肤科杂志,2008,37(7)：469-470.
[48]钱方,杨志波.活血消银片对银屑病患者皮损中微血管密度的影响[J].湖南中医药大学学报,2012,32(3)：59-63.
[49]刘卫红,李萍,王萍等.银屑病血热证患者治疗前后血浆代谢组学分析[J].首都医科大学学报,2009,30(4)：430-435.
[50]宋少刚,陈振德,李艳等.银屑胶囊对急性血痕模型大鼠血液流变学的影响[J].广东药学,2003,13(6)：30-32.
[51]肖青林,司本辉,吴康智等.不同剂量丹参治疗银屑病患者后血液流变学改变[J].中华皮肤科杂志,2002,33(6)：414-415.
[52]周萌,陈会茹,陶林昌.血府逐疲汤治疗寻常型银屑病3喇临床观察[J].北京中医药大学学报,2005：(5)：14-16.
[1]张建中,银屑病的流行病学与危险因素[J].实用医院临床杂志,2013,10(1)：4-6.
[2]Fuchs E. Epidermal differentiation:the bare essentials [J]Cell Biol,1990,71 (6): 7-14.
[3]Kristine E. Nograles.MD, Batya Davidovici,MD, et al.New insights in the Immuno-logic Basis of Psoriasis[J]. Semin Cutan Med Surg.2010,29(1):3-9.
[4]赵艳霞.T淋巴细胞与银屑病发病机制的关系[J].中国中西医结合皮肤性病学杂志,2010,(6)：398-400.
[5]Hoyne GF, Le Roux I,Corsin-Jimenez M, et al. Serratel-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. Int Immunol [J].2000,12(2):177-85.
[6]Maekawa Y, Tsukumo S, Chiba S, et al. Deltal-Notch3 interactions bias the funct-ional differentiation of activated CD4+ T cells[J]. Immunity.2003,19(4):549-559.
[7]Benson RA, Adamson K, Corsin-J imenez M. Notchl co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 product ion[J]. Eur J Imm unol,2005,35:859-869.
[8]侯瑞霞,尹国华,李新华等.银屑病患者骨髓CD34+细胞Notch受体的表达[J].中华微生物学和免疫学杂志,2009,29(3)：212.
[9]Zhang K, Hou R, Niu X,et al. Decreased colony formation of high proliferative potential colony-forming cells and granulocyte-macrophage colony-forming units and increased Hes-1 expression in bone marrow mononuclear cells from patients with psoriasis [J].Br J Dermatol.2010,163(1):93-101.
[10]李佳欢,傅涛.Notch信号途径对T细胞分化发育及细胞因子的影响[J].现代生物医学进展,2009,9(2)：343-5,361.
[11]Mak RK,Hundhausen C,Nestle FO.Progress in understanding the immunopathog-enesis of psoriasis[J].Actas Dermosifiliogr.2009,100(2):2-13.
[12]郁博.NF-κB/IκB信号通路与皮肤病[J].重庆医学,2010,39(11)：1450-3.
[13]Yu XJ, Li CY, Xu YH, et al. Calcitonin gene-related peptide increases prolifera-tion of human HaCaT keratinocytes by activation of MAP kinases[J]. Cell Biol Int.2009,33(11):1144-8.
[14]Morhenn VB. Langerhans cells may trigger the psoriatic disease process via production of nitric oxide[J]. Immunol Today.1997,18 (9):433-6.
[15]Gudjonsson JE, Johnston A, Stoll SW, et al.Evidence for altered Wnt signaling in psoriatic skin[J].J Invest Dermatol.2010,130(7):1849-59.
[16]Tsuruta D. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis[J]. Recent Pat Inflamm Allergy Drug Discov,2009,3(1):40.
[17]Lizzul PF, Aphale A,Malaviya R, et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept [J]. J Invest Dermatol.2005,124(6):1275-83.
[18]Soegaard-Madsen L, Johansen C, Iversen L, et al. Adalimumab therapy rapidly inhi-bits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement[J]. Br J Dermatol.2010,162 (6):1216-23.
[19]Rasmussen MK, Iversen L, Johansen C, et al. IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response[J]. Inflamm Res.2008,57 (7):329-39.
[20]Skvara H, Daw id M, Kleyn E, The PKC inhibitor AEB071 may be a therapeutic option for psoriasis[J].J Clin Invest.2008,118(9):3151-9.
[21]Morgan, T. The theory of the gene[J]. Am. Nat.1917,51(9):513-44.
[22]Baron M,Aslam H,FlaszaM,et al.Multiple levels of Notch signal regulation (review).Mol Membr Bi01,2002,19(1):27.
[23]Wheeler SR, Stagg SB, Crews ST. Multiple Notch signaling events control Drosoph-ila CNS midline neurogenesis, gliogenesis and neuronal identity, Develop-ment,2008,135 (18):3071.
[24]Lothaire P,de Azambuja E, Dequanter D, et al. Molecular markersofheadand neck squalnous cell carcinoma:promising signs in needof prospective evaluation. Head Neck,2006,28(3):256-269.
[25]Okuyama R, Nguyen BC, Talora C, et al. Hiigh commitment of emblyomc keratinocytes to terminal differentiation through a Notch-1-caspase 3 regulatory mechanism [J]. Dev Cell,2004,6(4):551-562.
[26]Rangarajan TalomC,Okuyama R et al. Noah signaling is a direct determinant of keratinoeyte growth arrest and entry into differentiation[J]. EMBOJ,2001,20(34): 27-36.
[27]Niekoloff BJ, Qin JZ, Chaturvedi V, et al. Jagged-1 mediated activation Of notch signaling induces complete maturation of human kemtinocytes through NF-kappaB and PPARgamma[J]. Cell Death Differ,2002,9(8):40-55.
[28]夏炜,潘宝华,刘蓓,等.Notch受体、配体及下游基因在增牛性瘢痕表皮中的表达[J]中 华整形外科杂志,2009,25(1)：41-45.
[29]BlanpainCJ-owry WE,Pasolli Fuchs E.Canonical notch signaling Functionsasa commitmentswitch in the epidermal lineage [J]GenesDev,2006,20(30):22-35.
[30]Perez-Cabezas B, Naranjo-Gomez M, Bastos-Amador P, et al.Ligation of Notch receptors in human conventional and plasmacytoid dendritic cells differentially regulates cytokine and chemokine secretion and modulates Th cell polarization[J]J Immunol,2011,186 (12):7006-7015.
[31]The luJ, Rossio P, Favier B. Notch signalling is linked to epidermal cell differ-entiation level in basal cell carcinoma,psoriasis and wound healing[J]. BMC Dermatol.2002,29 (2):7.
[32]熊英.Jaggedl蛋白在银屑病、基底细胞癌及皮肤鳞癌发病机制中作用的研究[D].中国协和医科大学：中国协和医科大学,2010.
[33]NguyenBC,Lefort K,MandinovaA,et al.Cross-regulation between Noahand p63 in kemtinoeyte commitment to differentiation[J]. GenesDev,2006,20(8):1028-1042.
[34]Okuyama IL OgawaE, Nagoshi H'et al,p53 homologue, p49/p63.Mainmins the immaturity of kemtinocytestem cells by inhibiting Notch-1 activity[J]. Oncogene, 2007,26 (31):4478-4488.
[35]Bugeon L,Gardner LM, Rose A, et al. Cutting edge:Notch signaling induces a distinct cytokine profile in dendritic cells that supports T cell-mediated regulation and IL-2-dependent IL-17 production[J]. J Immunol,2008,181 (12):8189-8193.
[36]Perez-Cabezas B, Naranjo-G 6 mez M, Bastos-Amador P, et al.Ligation of Notch receptors in human conventional and plasmacytoid dendritic cells differentially regulates cytokine and chemokine secretion and modulates Th cell polarization [J]. J Immunol,2011,186 (12):7006-7015.
[37]Feng F,Wang YC, Hu XB, et al.The transcription factor RBP-J-mediated signaling is essential for dendritic cells to evoke efficient anti-tumor immune responses in mice[J].Mol Cancer,2010,9:90.
[38]Sekine C,Moriyama Y, Koyanagi A,et al. Differential regulation of splenic CD8-dendritic cells and marginal zone B cells by Notch ligands[J]Int Immunol,2009, 21 (3):295-30.
[39]Wang YC, Hu XB, He F, et al. Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4[J],J Biol Chem,2009,284 (23):15993-16003.
[40]Napolitani G, Rinaldi A, Bertoni F, et al. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type lpolarizing program in dendritic cells[J]. Nat Immunol,2005,6(8):769-776.
[41]Feng F,Yang J, Tong L, et al. OP9-DL1 cell co-culture enhances anti-tumour immu-nity of mouse bone marrow-derived dendritic cells [J]. Cell Biol Int,2012,36(3):297-303.
[42]Stallwood Y, Briend E, Ray KM, et al. Small interfering RNA-mediated knockdown of notch ligands in primary CD4+ T cells and den-dritic cells enhances cytokine production [J]. J Immunol,2006,177(2):885-895.
[43]Skokos D, Nussenzweig MC. CD8-DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS[J].J Exp Med,2007,204(7):1525-1531.
[44]Lei L, Xu A, Panin VM, et al.o-fucose site in the ligand binding domain inhibits Notch activation[J], Development,2003,130 (26):6411-6421.
[45]Ikeuchi T, Sisodia SS. The Notch ligands, Deltal and Jagged2,aresubstrates for presenil in-dependent 'gamma-secretase' cleavage [J]. J Biol Chem,2003,278 (10): 7751-7754.
[46]Baldi A,Falco M, Luca L, et al.Characterization of tissue specific expression of Notch-I in human tissues [J]. Biol Cell,2004,96(4):303-311.
[47]Maillard I, Fang T, Pear WS, Regulation of lymphoid development, differentiation and function by the Notch pathway[J]. Annu Rev Immunol,2005,23(1):945-974.
[48]Yan XQ, Sarmiento U, Sun Y, et al. A novel Notch ligand, D114, induces T-cell leuke-mia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer[J]. Blood,2001,98 (13):3793-3799.
[49]Tanigaki K, Tsuji M, Yamamoto N, et al. Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling[J]. Immunity,2004,20 (5):611-622.
[50]Radtke F, Ferrero I, Wilson A, et al. Notchl deficiency dissociates the intrathymi c development of dendritic cells and T cells [J]. J Exp Med,2000,191(7):1085-1094.
[51]Vigouroux S, Yvon E, Wagner HJ, et al. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes [J],J Virol,2003,77 (20):10872-10880.
[52]McKenzie GJ, Khan M, Briend E, et al. Notch:a unique therapeutic target for immu-nomodulation[J]. Expert Opin Ther Target, s,2005,9(2):395-410.
[1]郁博.NF-κB/IκB信号通路与皮肤病[J].重庆医学,2010；39(11)：1450-3.
[2]Yu XJ, Li CY, Xu YH, et al. Calcitonin gene-related peptide increases proliferation of human HaCaT keratinocytes by activation of MAP kinases[J].Cell Biol Int.2009; 33(11):1144-8.
[3]Morhenn VB. Langerhans cells may trigger the psoriatic disease process via production of nitric oxide [J]. Immunol Today.1997; 18 (9):433-6.
[4]Gudjonsson JE, Johnston A, Stoll SW, et al.Evidence for altered Wnt signaling in psoriatic skin[J]. J Invest Dermatol.2010; 130(7):1849-59.
[5]Tsuruta D. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis[J]. Recent Pat Inflamm Allergy Drug Discov,2009; 3(1):40.
[6]Lizzul PF, Aphale A, Malaviya R, et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept [J]. J Invest Dermatol.2005; 124 (6):1275-83.
[7]Soegaard-Madsen L, Johansen C, Iversen L, et al. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement [J]. Br J Dermatol.2010; 162 (6):1216-23.
[8]Rasmussen MK, Iversen L, Johansen C, et al. IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response[J]. Inflamm Res.2008; 57(7):329-39.
[9]Skvara H, Dawid M, Kleyn E, The PKC inhibitor AEB071 may be a therapeutic option for psoriasis [J]. J Clin Invest.2008; 118(9):3151-9.
[10]Hoyne GF, Le Roux I, Cor sin-Jimenez M, et al. Serratel-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. Int Immunol [J].2000; 12(2):177-85.
[11]Maekawa Y, Tsukumo S, Chiba S, et al. Deltal-Notch3 interactions bias the functional differentiation of activated CD4+ T cells[J]. Immunity. 2003; 19 (4):549-59.
[12]Benson RA, Adamson K, Corsin-J imenez M. Notchl co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 product ion [J].Eur J Imm unol,2005; 35:859-869.
[13]Zhang K, Hou R, Niu X,et al. Decreased colony formation of high proliferative potential colony-forming cells and granulocyte-macrophage colony-forming units and increased Hes-1 expression in bone marrow mononuclear cells from patients with psoriasis[J]. Br J Dermatol.2010; 163 (1):93-101.
[14]Tien AC, Rajan A, Bellen HJ. A Notch updated[J].J Cell Biol,2009, 184 (5):621-629.
[15]Radtke F, Wilson A, Mancini SJ,et al. Notch regulation of lymphocyte development and function [J]. Nat Immunol,2004,5(3):247-253.
[16]Maillard, I, Adler, S. H and Pear, W. S. Notch and the immune system[J]. Immunity,2003,19:781 791.
[17]赵艳霞.T淋巴细胞与银屑病发病机制的关系[J].中国中西医结合皮肤性病学杂志,2010；(6)：398-400.
[18]Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis [J].JAm Acad Dermatol.2006; 54(3 Suppl 2):S67-80.
[19]Mak RK, Hundhausen C, Nestle FO. Progress in understanding the immuno-pathogenesis of psoriasis[J]. Actas Dermosifiliogr.2009; 100(2):2-13.
[20]Hoyne GF, Le Roux I, Corsin-Jimenez M, et al. Serratel-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4 (+) T cells. Int Immunol [J].2000; 12 (2):177-85.
[21]Maekawa Y, Tsukumo S, Chiba S, et al. Deltal-Notch3 interactions bias the functional differentiation of activated CD4+ T cells[J]. Immunity. 2003; 19 (4):549-59.
[22]Benson RA, Adamson K, Corsin-J imenez M. Notchl co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production[J]. Bur J Imm unol,2005; 35:859-869
[23]侯瑞霞,尹国华,李新华等.银屑病患者骨髓CD34+细胞Notch受体的表达[J].中华微生物学和免疫学杂志,2009；29(3)：212.
[24]熊英.Jaggedl蛋白在银屑病、基底细胞癌及皮肤鳞癌发病机制中作用的研究[D].中国协和医科大学：中国协和医科大学,2010.
[25]Radtke F, Wilson A, Mancini SJ, et al. Notch regulation of lymphocyte development and function. Nat Immunol,2004,5 (3):247-253.
[26]Bigas A, Robert-Moreno A, Espinosa L. The Notch pathway in the developing hematopoietic system. Int J Dev Biol,2010,54(6-7):1175-1188.
[27]Takebe N, Ivy SP. Controversies in cancer stem cells:targeting embryonicsignaling pathways. Clin Cancer Res,2010,16 (12):3106-3112.
[28]Maillard, I, Adler, S. H and Pear, W. S. Notch and the immune system. Immunity,2003,19:781 791.
[29]Lauritsen JP, Wong GW, Lee SY, et al. Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity,2009, 31 (4):565-575.
[30]Feng N, Vegh P, Rothenberg EV, et al. Lineage divergence at the first TCR-dependent checkpoint:preferential γ δ and impaired α β T cell development in nonobese diabetic mice[J]. J Immunol,2011,186 (2):826-837.
[31]Mukher jee S,Schaller MA, Neupane R, et al.Regulation of T cell activation by Notch ligand, DLIA, promotes IL-17 production and rorc activation[J]. J Immunol,2009,182 (12):7381.7388.
[32]Pancewicz J, Taylor JM, Datta A, et al. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia [J]. PNAS,2010,107(38):16619-16624.
[33]Xiong J, Armato MA, Yankee TM. Immature single-positive CD8+ thymocytes represent the transition from Notch-dependent to Notch-independent T-cell development[J]. Immunol,2011,23(1):55-64.
[34]aron M, As lam H, FlaszaM, et al. Multiple levels of Notch signal regulation (review) [J].Mol Membr Bi01,2002,19 (1):27.
[35]heeler SR, Stagg SB, Crews ST.Multiple Notch signaling events control Drosophila CNS midline neurogenesis, gliogenesis and neuronal identity [J],Development,2008,135(18):3071.
[36]Thelu J, Rossio P, Favier B. Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing [J]. BMC Dermatol.2002; 29 (2):7.
[2]中医研究院广安门医院,朱仁康临床经验集[J].人民卫生出版社,1979,153-158.
[3]北京中医医院,赵炳南临床经验集[J].人民卫生出版社,1975,211-229.
[4]顾伯华外科经验集[J].上海人民出版社,1977,252.
[5]周鸣岐.辨证分型治疗银屑病302例[J].中医杂志,1989,30(5)：42-43.
[6]金起风.中华皮肤病学[J].中国医药科技出版社,2001,228-233.
[7]王萍,邓丙戌,孙丽蕴,张芃.张志礼中医辨证治疗银屑病方法及临床研究[J].中国中西医结合皮肤性病学杂志,2004,3(4)：19-193.
[8]于晓飞,吴秀艳,徐雯洁等.不同年代寻常型银屑病证候分布规律特点的现代文献研究[M].全国第十三届中医诊断学术年会论文汇编,2012：215-219.
[9]卢传坚,曾召,谢秀丽等.1979-2010年寻常型银屑病文献证候分布情况分析[J].中医杂志,2012,53(11)：959-961.
[10]谢知音,白彦萍,杨顶权.银屑病中医体质与辨证分型的相关性研究[J].中华中医药杂志.2009,(6)：823-825.
[11]皮巨川.犀角地黄汤加味治疗寻常型银屑病26例疗效观察[J],贵阳中医学院学报,1995,17(1)：57.
[12]张志礼,200例银屑病中医辨证论治的体会[J].中华医学杂志,1974,(4)：205-207.
[13]白英华,田静,凉血四根汤治疗血热型银屑病疗效观察[J].辽宁中医杂志,2006,11(33)：1433-1434.
[14]瞿幸,牛福玲,赵丽平.消银解毒饮治疗银屑病血热证85例临床研究[J].中医杂志,2001,42(2)：103-104.
[15]郝平生.加味凉血消风散治疗寻常型进行期血热证银屑病30例疗效观察[J].中药与临床,2011,2(3)：50-58.
[16]王素梅.皮炎汤治疗寻常型银屑病血热证的临床疗效[J].求医问药,2012,10(8)：160.
[17]徐明.清热凉血汤治疗寻常型银屑病血热证临床疗效观察[J].辽宁中医药大学学报,2013,15(1)：177-178.
[18]吕世超,赵梓刚,郭雁冰等.蛇花颗粒治疗寻常型银屑病(血热型)临床研究[J].中国中医药信息杂志,2008,7,15(7)：78-79.
[19]李娟,藏亮,黄婷等.生元饮治疗血热型银屑病的临床观察[J].黑龙江中医药,2010,3：16-17.
[20]刘志勇,王莒生,王萍等.凉血解毒汤治疗白疙(寻常型银屑病)血热证的临床观察[J].世界中西医结合杂志,2010,5(40)：317-320.
[21]李福伦,李斌,徐蓉等.芩珠凉血合剂治疗血热证银屑病的随机对照临床研究[J].中西医结合学 报,2008,6(6)：586-590.
[22]马丽俐,骆丰,余土根等.清热凉血方对血热型寻常型银屑病患者血清VEGF水平和PASI指数的影响[J].中国中医药科技,2008,15(3)：168-169.
[23]张春红,杜锡贤,张春敏.祛银汤治疗血热证银屑病临床观察及其对外周血OPN和VEGF表达的影响[J].中国皮肤性病学杂志,2011,25(3)：228-230.
[24]张红,徐晓光,顾军等.消银方治疗血热证型银屑病患者的疗效及对外周血Thl/Th2平衡的影响[J].中国中西医结合杂志,2008,28(8)：683-685.
[25]刘和平,孟凡颖.自拟养血润肤汤治疗血燥型银屑病40例疗效分析[J],中国医药导报,2011,08(5)：66.
[26]李忠信.养血祛风汤治疗寻常型银屑病40例疗效观察[J].山东中医杂志,2004,23(3)：149-150.
[27]周德瑛,张丰川,李元文等.养血消银解毒饮治疗寻常型银屑病血燥证52例[J].中国中医急症,2010,19(8)：1430-1431.
[28]陆茂,叶俊儒,张云光等.窄谱中波紫外线联合中药治疗血燥型银屑病的疗效观察[J].四川中医,2009,27(12)：102-103.
[29]张永.桃红四物汤治疗银屑病的方药研究探析[J],光明中医,2008,23(10)：1471-1472.
[30]王秀敏,于小玲,张其红.银屑病患者活血化瘀治疗前后血液流变学和甲襞微循环的变化[J].滨州医学院学报,1999,22(6)535-536.
[31]郭建辉,郭雯,付红娟等.从络病论治寻常型银屑病60例临床观察[J].中医药导报,2012,18(5)：32-33.
[32]邱实,谭升顺,孙治平等.活血散疲消银汤治疗寻常型银屑病血疲证的临床研究[J].中药材杂志,2005：25(5)：442-444.
[33]崔秀梅,柏燕军,卢淑梅等.养血消银颗粒剂治疗银屑病血虚证39例临床研究[A].2003中国中西医结合皮肤性病学术会议论文汇编[C],2003：503-504.
[34]范延华,孔连委,张文宪等.中药联合紫外光治疗银屑病血虚证60例[J].现代中西医结合杂志,2010,19(24)：3075.
[35]吴燕军,刘红霞,姚岚等.中医治疗银屑病的用药规律研究[J],北京中医药,2009,28(9)：701-702.
[36]张小蒙,雷公藤的药理作用和临床应用研究进展,临床合理用药杂志[J],2012,05(20)：180.
[37]周萌.银屑病血瘀证的思考[J],中国医学文摘(皮肤科学,2006,23(5)：337-338.
[38]梁莹,周萌.活血化瘀中药复方对小鼠银屑病模型的影响[J],中国医药导报2009,6(26)：9-11.
[39]高依卿,陈玉春.气血阴阳补益方剂影响免疫和造血功能的研究现状[J],中药材,2001,24(5)：383-385.
[40]邢捷.益气健脾、补益气血中药促进难愈性创面愈合的机制研究[D],上海中医药大学,硕士论 文,2007.
[41]李斌,王婕,范斌等.中医“血分论治”对寻常型银屑病患者外周血单个核细胞IFN-γ/IL-4表达影响的实验研究[J].上海中医药杂志,2007,41(11)：5-6.
[42]范斌,李斌,沈健雄等.凉血和活血中药对银屑病患者不同时期细胞因子的影响[J].中国中西医结合皮肤性病学杂志,2006,5(2)：70-71.
[43]夏梦,段行武,高永红等.消银解毒饮调控银屑病血热证肿瘤坏死因子-α的相关研究[J].中国中西医结合皮肤性病学杂志,2011,10(2)：79-82.
[44]刘志勇,王莒生,王萍等.凉血解毒汤治疗白疙(寻常型银屑病)血热证的临床观察[J].世界中西医结合杂志,2010,5(40)：317-320.
[45]王丽华,张蕾,刘欣等.养血解毒汤对血燥型银屑病患者血清免疫细胞因子的调节[J],辽宁中医药大学学报,2010,11(11)：69-71.
[46]林熙然.抑制血管生成与银屑病的中西医结合治疗研究[J],中国中西医结合皮肤性病学杂志,2006,5：187-191.
[47]刘国海,张晓云,刘俊敏等.活血化瘀法治疗银屑病疗效与血液流变学变化的关系[J],临床皮肤科杂志,2008,37(7)：469-470.
[48]钱方,杨志波.活血消银片对银屑病患者皮损中微血管密度的影响[J].湖南中医药大学学报,2012,32(3)：59-63.
[49]刘卫红,李萍,王萍等.银屑病血热证患者治疗前后血浆代谢组学分析[J].首都医科大学学报,2009,30(4)：430-435.
[50]宋少刚,陈振德,李艳等.银屑胶囊对急性血痕模型大鼠血液流变学的影响[J].广东药学,2003,13(6)：30-32.
[51]肖青林,司本辉,吴康智等.不同剂量丹参治疗银屑病患者后血液流变学改变[J].中华皮肤科杂志,2002,33(6)：414-415.
[52]周萌,陈会茹,陶林昌.血府逐疲汤治疗寻常型银屑病3喇临床观察[J].北京中医药大学学报,2005：(5)：14-16.
[1]张建中,银屑病的流行病学与危险因素[J].实用医院临床杂志,2013,10(1)：4-6.
[2]Fuchs E. Epidermal differentiation:the bare essentials [J]Cell Biol,1990,71 (6): 7-14.
[3]Kristine E. Nograles.MD, Batya Davidovici,MD, et al.New insights in the Immuno-logic Basis of Psoriasis[J]. Semin Cutan Med Surg.2010,29(1):3-9.
[4]赵艳霞.T淋巴细胞与银屑病发病机制的关系[J].中国中西医结合皮肤性病学杂志,2010,(6)：398-400.
[5]Hoyne GF, Le Roux I,Corsin-Jimenez M, et al. Serratel-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. Int Immunol [J].2000,12(2):177-85.
[6]Maekawa Y, Tsukumo S, Chiba S, et al. Deltal-Notch3 interactions bias the funct-ional differentiation of activated CD4+ T cells[J]. Immunity.2003,19(4):549-559.
[7]Benson RA, Adamson K, Corsin-J imenez M. Notchl co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 product ion[J]. Eur J Imm unol,2005,35:859-869.
[8]侯瑞霞,尹国华,李新华等.银屑病患者骨髓CD34+细胞Notch受体的表达[J].中华微生物学和免疫学杂志,2009,29(3)：212.
[9]Zhang K, Hou R, Niu X,et al. Decreased colony formation of high proliferative potential colony-forming cells and granulocyte-macrophage colony-forming units and increased Hes-1 expression in bone marrow mononuclear cells from patients with psoriasis [J].Br J Dermatol.2010,163(1):93-101.
[10]李佳欢,傅涛.Notch信号途径对T细胞分化发育及细胞因子的影响[J].现代生物医学进展,2009,9(2)：343-5,361.
[11]Mak RK,Hundhausen C,Nestle FO.Progress in understanding the immunopathog-enesis of psoriasis[J].Actas Dermosifiliogr.2009,100(2):2-13.
[12]郁博.NF-κB/IκB信号通路与皮肤病[J].重庆医学,2010,39(11)：1450-3.
[13]Yu XJ, Li CY, Xu YH, et al. Calcitonin gene-related peptide increases prolifera-tion of human HaCaT keratinocytes by activation of MAP kinases[J]. Cell Biol Int.2009,33(11):1144-8.
[14]Morhenn VB. Langerhans cells may trigger the psoriatic disease process via production of nitric oxide[J]. Immunol Today.1997,18 (9):433-6.
[15]Gudjonsson JE, Johnston A, Stoll SW, et al.Evidence for altered Wnt signaling in psoriatic skin[J].J Invest Dermatol.2010,130(7):1849-59.
[16]Tsuruta D. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis[J]. Recent Pat Inflamm Allergy Drug Discov,2009,3(1):40.
[17]Lizzul PF, Aphale A,Malaviya R, et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept [J]. J Invest Dermatol.2005,124(6):1275-83.
[18]Soegaard-Madsen L, Johansen C, Iversen L, et al. Adalimumab therapy rapidly inhi-bits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement[J]. Br J Dermatol.2010,162 (6):1216-23.
[19]Rasmussen MK, Iversen L, Johansen C, et al. IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response[J]. Inflamm Res.2008,57 (7):329-39.
[20]Skvara H, Daw id M, Kleyn E, The PKC inhibitor AEB071 may be a therapeutic option for psoriasis[J].J Clin Invest.2008,118(9):3151-9.
[21]Morgan, T. The theory of the gene[J]. Am. Nat.1917,51(9):513-44.
[22]Baron M,Aslam H,FlaszaM,et al.Multiple levels of Notch signal regulation (review).Mol Membr Bi01,2002,19(1):27.
[23]Wheeler SR, Stagg SB, Crews ST. Multiple Notch signaling events control Drosoph-ila CNS midline neurogenesis, gliogenesis and neuronal identity, Develop-ment,2008,135 (18):3071.
[24]Lothaire P,de Azambuja E, Dequanter D, et al. Molecular markersofheadand neck squalnous cell carcinoma:promising signs in needof prospective evaluation. Head Neck,2006,28(3):256-269.
[25]Okuyama R, Nguyen BC, Talora C, et al. Hiigh commitment of emblyomc keratinocytes to terminal differentiation through a Notch-1-caspase 3 regulatory mechanism [J]. Dev Cell,2004,6(4):551-562.
[26]Rangarajan TalomC,Okuyama R et al. Noah signaling is a direct determinant of keratinoeyte growth arrest and entry into differentiation[J]. EMBOJ,2001,20(34): 27-36.
[27]Niekoloff BJ, Qin JZ, Chaturvedi V, et al. Jagged-1 mediated activation Of notch signaling induces complete maturation of human kemtinocytes through NF-kappaB and PPARgamma[J]. Cell Death Differ,2002,9(8):40-55.
[28]夏炜,潘宝华,刘蓓,等.Notch受体、配体及下游基因在增牛性瘢痕表皮中的表达[J]中 华整形外科杂志,2009,25(1)：41-45.
[29]BlanpainCJ-owry WE,Pasolli Fuchs E.Canonical notch signaling Functionsasa commitmentswitch in the epidermal lineage [J]GenesDev,2006,20(30):22-35.
[30]Perez-Cabezas B, Naranjo-Gomez M, Bastos-Amador P, et al.Ligation of Notch receptors in human conventional and plasmacytoid dendritic cells differentially regulates cytokine and chemokine secretion and modulates Th cell polarization[J]J Immunol,2011,186 (12):7006-7015.
[31]The luJ, Rossio P, Favier B. Notch signalling is linked to epidermal cell differ-entiation level in basal cell carcinoma,psoriasis and wound healing[J]. BMC Dermatol.2002,29 (2):7.
[32]熊英.Jaggedl蛋白在银屑病、基底细胞癌及皮肤鳞癌发病机制中作用的研究[D].中国协和医科大学：中国协和医科大学,2010.
[33]NguyenBC,Lefort K,MandinovaA,et al.Cross-regulation between Noahand p63 in kemtinoeyte commitment to differentiation[J]. GenesDev,2006,20(8):1028-1042.
[34]Okuyama IL OgawaE, Nagoshi H'et al,p53 homologue, p49/p63.Mainmins the immaturity of kemtinocytestem cells by inhibiting Notch-1 activity[J]. Oncogene, 2007,26 (31):4478-4488.
[35]Bugeon L,Gardner LM, Rose A, et al. Cutting edge:Notch signaling induces a distinct cytokine profile in dendritic cells that supports T cell-mediated regulation and IL-2-dependent IL-17 production[J]. J Immunol,2008,181 (12):8189-8193.
[36]Perez-Cabezas B, Naranjo-G 6 mez M, Bastos-Amador P, et al.Ligation of Notch receptors in human conventional and plasmacytoid dendritic cells differentially regulates cytokine and chemokine secretion and modulates Th cell polarization [J]. J Immunol,2011,186 (12):7006-7015.
[37]Feng F,Wang YC, Hu XB, et al.The transcription factor RBP-J-mediated signaling is essential for dendritic cells to evoke efficient anti-tumor immune responses in mice[J].Mol Cancer,2010,9:90.
[38]Sekine C,Moriyama Y, Koyanagi A,et al. Differential regulation of splenic CD8-dendritic cells and marginal zone B cells by Notch ligands[J]Int Immunol,2009, 21 (3):295-30.
[39]Wang YC, Hu XB, He F, et al. Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by notch signaling through the up-regulation of CXCR4[J],J Biol Chem,2009,284 (23):15993-16003.
[40]Napolitani G, Rinaldi A, Bertoni F, et al. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type lpolarizing program in dendritic cells[J]. Nat Immunol,2005,6(8):769-776.
[41]Feng F,Yang J, Tong L, et al. OP9-DL1 cell co-culture enhances anti-tumour immu-nity of mouse bone marrow-derived dendritic cells [J]. Cell Biol Int,2012,36(3):297-303.
[42]Stallwood Y, Briend E, Ray KM, et al. Small interfering RNA-mediated knockdown of notch ligands in primary CD4+ T cells and den-dritic cells enhances cytokine production [J]. J Immunol,2006,177(2):885-895.
[43]Skokos D, Nussenzweig MC. CD8-DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS[J].J Exp Med,2007,204(7):1525-1531.
[44]Lei L, Xu A, Panin VM, et al.o-fucose site in the ligand binding domain inhibits Notch activation[J], Development,2003,130 (26):6411-6421.
[45]Ikeuchi T, Sisodia SS. The Notch ligands, Deltal and Jagged2,aresubstrates for presenil in-dependent 'gamma-secretase' cleavage [J]. J Biol Chem,2003,278 (10): 7751-7754.
[46]Baldi A,Falco M, Luca L, et al.Characterization of tissue specific expression of Notch-I in human tissues [J]. Biol Cell,2004,96(4):303-311.
[47]Maillard I, Fang T, Pear WS, Regulation of lymphoid development, differentiation and function by the Notch pathway[J]. Annu Rev Immunol,2005,23(1):945-974.
[48]Yan XQ, Sarmiento U, Sun Y, et al. A novel Notch ligand, D114, induces T-cell leuke-mia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer[J]. Blood,2001,98 (13):3793-3799.
[49]Tanigaki K, Tsuji M, Yamamoto N, et al. Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling[J]. Immunity,2004,20 (5):611-622.
[50]Radtke F, Ferrero I, Wilson A, et al. Notchl deficiency dissociates the intrathymi c development of dendritic cells and T cells [J]. J Exp Med,2000,191(7):1085-1094.
[51]Vigouroux S, Yvon E, Wagner HJ, et al. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes [J],J Virol,2003,77 (20):10872-10880.
[52]McKenzie GJ, Khan M, Briend E, et al. Notch:a unique therapeutic target for immu-nomodulation[J]. Expert Opin Ther Target, s,2005,9(2):395-410.
[1]郁博.NF-κB/IκB信号通路与皮肤病[J].重庆医学,2010；39(11)：1450-3.
[2]Yu XJ, Li CY, Xu YH, et al. Calcitonin gene-related peptide increases proliferation of human HaCaT keratinocytes by activation of MAP kinases[J].Cell Biol Int.2009; 33(11):1144-8.
[3]Morhenn VB. Langerhans cells may trigger the psoriatic disease process via production of nitric oxide [J]. Immunol Today.1997; 18 (9):433-6.
[4]Gudjonsson JE, Johnston A, Stoll SW, et al.Evidence for altered Wnt signaling in psoriatic skin[J]. J Invest Dermatol.2010; 130(7):1849-59.
[5]Tsuruta D. NF-kappaB links keratinocytes and lymphocytes in the pathogenesis of psoriasis[J]. Recent Pat Inflamm Allergy Drug Discov,2009; 3(1):40.
[6]Lizzul PF, Aphale A, Malaviya R, et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept [J]. J Invest Dermatol.2005; 124 (6):1275-83.
[7]Soegaard-Madsen L, Johansen C, Iversen L, et al. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement [J]. Br J Dermatol.2010; 162 (6):1216-23.
[8]Rasmussen MK, Iversen L, Johansen C, et al. IL-8 and p53 are inversely regulated through JNK, p38 and NF-kappaB p65 in HepG2 cells during an inflammatory response[J]. Inflamm Res.2008; 57(7):329-39.
[9]Skvara H, Dawid M, Kleyn E, The PKC inhibitor AEB071 may be a therapeutic option for psoriasis [J]. J Clin Invest.2008; 118(9):3151-9.
[10]Hoyne GF, Le Roux I, Cor sin-Jimenez M, et al. Serratel-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. Int Immunol [J].2000; 12(2):177-85.
[11]Maekawa Y, Tsukumo S, Chiba S, et al. Deltal-Notch3 interactions bias the functional differentiation of activated CD4+ T cells[J]. Immunity. 2003; 19 (4):549-59.
[12]Benson RA, Adamson K, Corsin-J imenez M. Notchl co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 product ion [J].Eur J Imm unol,2005; 35:859-869.
[13]Zhang K, Hou R, Niu X,et al. Decreased colony formation of high proliferative potential colony-forming cells and granulocyte-macrophage colony-forming units and increased Hes-1 expression in bone marrow mononuclear cells from patients with psoriasis[J]. Br J Dermatol.2010; 163 (1):93-101.
[14]Tien AC, Rajan A, Bellen HJ. A Notch updated[J].J Cell Biol,2009, 184 (5):621-629.
[15]Radtke F, Wilson A, Mancini SJ,et al. Notch regulation of lymphocyte development and function [J]. Nat Immunol,2004,5(3):247-253.
[16]Maillard, I, Adler, S. H and Pear, W. S. Notch and the immune system[J]. Immunity,2003,19:781 791.
[17]赵艳霞.T淋巴细胞与银屑病发病机制的关系[J].中国中西医结合皮肤性病学杂志,2010；(6)：398-400.
[18]Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis [J].JAm Acad Dermatol.2006; 54(3 Suppl 2):S67-80.
[19]Mak RK, Hundhausen C, Nestle FO. Progress in understanding the immuno-pathogenesis of psoriasis[J]. Actas Dermosifiliogr.2009; 100(2):2-13.
[20]Hoyne GF, Le Roux I, Corsin-Jimenez M, et al. Serratel-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4 (+) T cells. Int Immunol [J].2000; 12 (2):177-85.
[21]Maekawa Y, Tsukumo S, Chiba S, et al. Deltal-Notch3 interactions bias the functional differentiation of activated CD4+ T cells[J]. Immunity. 2003; 19 (4):549-59.
[22]Benson RA, Adamson K, Corsin-J imenez M. Notchl co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production[J]. Bur J Imm unol,2005; 35:859-869
[23]侯瑞霞,尹国华,李新华等.银屑病患者骨髓CD34+细胞Notch受体的表达[J].中华微生物学和免疫学杂志,2009；29(3)：212.
[24]熊英.Jaggedl蛋白在银屑病、基底细胞癌及皮肤鳞癌发病机制中作用的研究[D].中国协和医科大学：中国协和医科大学,2010.
[25]Radtke F, Wilson A, Mancini SJ, et al. Notch regulation of lymphocyte development and function. Nat Immunol,2004,5 (3):247-253.
[26]Bigas A, Robert-Moreno A, Espinosa L. The Notch pathway in the developing hematopoietic system. Int J Dev Biol,2010,54(6-7):1175-1188.
[27]Takebe N, Ivy SP. Controversies in cancer stem cells:targeting embryonicsignaling pathways. Clin Cancer Res,2010,16 (12):3106-3112.
[28]Maillard, I, Adler, S. H and Pear, W. S. Notch and the immune system. Immunity,2003,19:781 791.
[29]Lauritsen JP, Wong GW, Lee SY, et al. Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity,2009, 31 (4):565-575.
[30]Feng N, Vegh P, Rothenberg EV, et al. Lineage divergence at the first TCR-dependent checkpoint:preferential γ δ and impaired α β T cell development in nonobese diabetic mice[J]. J Immunol,2011,186 (2):826-837.
[31]Mukher jee S,Schaller MA, Neupane R, et al.Regulation of T cell activation by Notch ligand, DLIA, promotes IL-17 production and rorc activation[J]. J Immunol,2009,182 (12):7381.7388.
[32]Pancewicz J, Taylor JM, Datta A, et al. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia [J]. PNAS,2010,107(38):16619-16624.
[33]Xiong J, Armato MA, Yankee TM. Immature single-positive CD8+ thymocytes represent the transition from Notch-dependent to Notch-independent T-cell development[J]. Immunol,2011,23(1):55-64.
[34]aron M, As lam H, FlaszaM, et al. Multiple levels of Notch signal regulation (review) [J].Mol Membr Bi01,2002,19 (1):27.
[35]heeler SR, Stagg SB, Crews ST.Multiple Notch signaling events control Drosophila CNS midline neurogenesis, gliogenesis and neuronal identity [J],Development,2008,135(18):3071.
[36]Thelu J, Rossio P, Favier B. Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing [J]. BMC Dermatol.2002; 29 (2):7.